NeuroRPM is a digital health technology company developing a mobile health and data analytics platform to empower individuals living with neurodegenerative diseases. Based in Washington, D.C., NeuroRPM is being integrated into neurology practices, advancing data-driven care and improving patient management. Our mission is to digitally transform care for a broad range of neurodegenerative conditions by seamlessly integrating the NeuroRPM platform with doctors, patients, and industry partners. NeuroRPM is also used in therapy research and development for symptom control and disease modification with participating partners.

​

On March 17, 2023, NeuroRPM was cleared by the FDA for use to monitor Parkinson's disease on Apple Watch for Parkinson's disease. Please read our press release. 

 

You may register with us to learn more about our technology and get updates as they happen.  Please follow this link to register with us.